Enzymotec Announces Publication Acceptance Of Clinical Study Results On K-REAL™ Usage Health Benefits
MIGDAL HA'EMEQ, Israel, Dec. 3, 2013 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, announced today the acceptance for future publication of its clinical study results evaluating the health benefits of K-REAL™, krill oil, compared with fish oil.
Help employers find you! Check out all the jobs and post your resume.